Perceived Stress is Associated with Impaired T-Cell Response to HPV16 in Women with Cervical Dysplasia
Infection with high-risk subtypes of human papillomavirus (HPV) is a central factor in the development of cervical neoplasia. Cell-mediated immunity against HPV16 plays an important role in the resolution of HPV infection and in controlling cervical disease progression. Research suggests that stress is associated with cervical disease progression, but few studies have examined the biological mechanisms that may be driving this association.
This study examines whether stress is associated with immune response to HPV16 among women with cervical dysplasia.
Seventy-four women presenting for colposcopy completed measures of health behaviors, stressful life events and perceived stress. A blood sample was obtained to evaluate proliferative T-cell response to HPV16, and a cervical sample was obtained during gynecologic exam for HPV-typing.
More than 55% tested positive for one or more HPV subtypes. Women who did not show proliferative responses to HPV (i.e. non-responders) were more likely to be HPV+ compared to women who had a response (i.e. responders). Consistent with study hypotheses, logistic regression revealed that higher levels of perceived stress were associated with a non-response to HPV16, controlling for relevant covariates. Stressful life events were not associated with T-cell response to HPV.
Higher levels of perceived stress are associated with impaired HPV-specific immune response in women with cervical dysplasia, suggesting a potential mechanism by which stress may influence cervical disease progression.
- Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992; 327: 1272–1278. CrossRef
- Stoler MH. A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis. Am J Obstet Gynecol. 1996; 175: 1091–1098. CrossRef
- Wolf JK, Franco EL, Arbeit JM, et al. Innovations in understanding the biology of cervical cancer. Cancer. 2003; 98: 2064–2069. CrossRef
- Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J. 2003; 9: 348–359. CrossRef
- Mitchell MF, Tortolero-Luna G, Wright T, et al. Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monographs. 1996; 21: 17–25.
- Schoell WMJ, Janicek MF, Mirhashemi R. Epidemiology and biology of cervical cancer. Sem Surg Oncol. 1999; 16: 203–211. CrossRef
- Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. J Am Med Assoc. 2007; 297: 813–819. CrossRef
- Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst. 2002; 94: 1406–1414.
- Schiffman MH, Castle P. Epidemiologic studies of a necessary causal risk factor: Human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst. 2003; 95: E2.
- Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst. 2005; 97: 1066–1071.
- Vermund SH, Kelley KF, Klein RS, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol. 1991; 165: 392–400.
- Maiman M. Management of cervical neoplasia in human immunodeficiency virus-infected women. J Natl Cancer Inst Monographs. 1998; 1998: 43–49.
- Hawes SE, Critchlow CW, Sow PS, et al. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst. 2006; 98: 100–109. CrossRef
- Kadish AS, Ho GYF, Burk RD, et al. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: Outcome of HPV infection and associated neoplasia. J Natl Cancer Inst. 1997; 89: 1285–1293. CrossRef
- Kadish AS, Timmins P, Wang Y, et al. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomark Prev. 2002; 11: 483–488.
- Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002; 347: 1645–1651. CrossRef
- Washam C. Two HPV vaccines yielding similar success. J Natl Cancer Inst. 2005; 97: 1030.
- Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005; 6: 271–278. CrossRef
- Mahdavi A, Monk BJ. Vaccines against human papillomavirus and cervical cancer: promises and challenges. Oncologist. 2005; 10: 528–538. CrossRef
- Shaw AR. Human papillomavirus vaccines in development: if they’re successful in clinical trials, how will they be implemented? Gynecol Oncol. 2005; 99: S246–S248. CrossRef
- Washam C. Targeting teens and adolescents for HPV vaccine could draw fire. J Natl Cancer Inst. 2005; 97: 1030–1031.
- Coker AL, Bond S, Madeleine MM, Luchok K, Pirisi L. Psychosocial stress and cervical neoplasia risk. Psychosom Med. 2003; 65: 644–651. CrossRef
- Pereira DB, Antoni MH, Danielson A, et al. Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med. 2003; 65: 427–434. CrossRef
- Glaser R, Kiecolt-Glaser JK. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Annals Behav Med. 1997; 19: 78–82.
- Kang DH, Fox C. Neuroendocrine and leukocyte responses and pulmonary function to acute stressors. Annals of Behav Med. 2000; 22: 276–285.
- Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology: Psychological influences on immune function and health. J Consult Clin Psychol. 2002; 70: 537–547. CrossRef
- Kiecolt-Glaser JK, Robles TF, Heffner KL, Loving TJ, Glaser R. Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann Oncol. 2002; 13(Suppl 4): 165–169.
- DeLongis A, Coyne J, Dakof G, Folkman S, Lazarus RS. Relationship of daily hassles, uplifts, and major life events to health status. Health Psychol. 1982; 1: 119–136. CrossRef
- Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res. 1967; 11: 213–218. CrossRef
- Cohen S, Kamarck TW, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983; 24: 385–396. CrossRef
- Cohen S, Doyle WJ, Skoner DP. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med. 1999; 61: 175–180.
- Cohen S, Hamrick N, Rodriguez MS, et al. Reactivity and vulnerability to stress-associated risk for upper respiratory illness. Psychosom Med. 2002; 64: 302–310. CrossRef
- Cohen S, Miller G, Rabin B. Psychological stress and antibody response to immunization: A critical review of the human literature. Psychosom Med. 2001; 63: 7–18.
- Cohen S, Rabin BS. Psychologic stress, immunity, and cancer. J Natl Cancer Inst. 1998; 90: 3–4. CrossRef
- Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991; 325: 606–612. CrossRef
- Luxton JC, Rowe AJ, Cridland JC, et al. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals. J Gen Virol. 1996; 77: 1585–1593.
- Nakagawa M, Stites DP, Farhat S, et al. T-cell proliferative response to human papillomavirus type 16 peptides: Relationship to cervical intraepithelial neoplasia. Clin Diagn Lab Immunol. 1996; 3: 205–210.
- Douglas SD, Hoffman PF, Borjeson J, Chessin LN. Studies on human peripheral blood lymphocytes in vitro. 3. Fine structural features of lymphocyte transformation by pokeweed mitogen. J Immunol. 1967; 98: 17–30.
- Douglas SD, Kamin RM, Fudenberg HH. Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol. 1969; 103: 1185–1195.
- Borkowsky W, Stanley K, Douglas SD, et al. Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis. 2000; 182: 96–103. CrossRef
- Sarkar AK, Tortolero-Luna G, Follen M, Sastry KJ. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study. Gynecol Oncol. 2005; 99: S251–S261. CrossRef
- Fang CY, Miller SM, Mills M, et al. The effects of avoidance on cytotoxic/suppressor T cells in women with cervical lesions. Psychooncology. 2003; 12: 590–598. CrossRef
- Gill D, Bible J, Biswas C, et al. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia. J Gen Virol. 1998; 79: 1971–1976.
- Steele JC, Mann CH, Rookes S, et al. T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. Br J Cancer. 2005; 93: 248–259. CrossRef
- Brummer O, Hollwitz B, Bohmer G, Kuhnle H, Petry KU. Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecol Oncol. 2006; 102: 517–522. CrossRef
- Goodkin K, Antoni MH, Blaney PH. Stress and hopelessness in the promotion of cervical intraepithelial neoplasia to invasive squamous cell carcinoma of the cervix. J Psychosom Res. 1986; 30: 67–76. CrossRef
- Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology and psychosomatic medicine: Back to the future. Psychosom Med. 2002; 64: 15–28.
- Paik IH, Toh KY, Lee C, Kim JJ, Lee SJ. Psychological stress may induce increased humoral and decreased cellular immunity. Behav Med. 2000; 26: 139–141. CrossRef
- Clerici M, Merola M, Ferrario E, et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst. 1997; 89: 245–250. CrossRef
- Peralta-Ramirez MI, Jimenez-Alonso J, Godoy-Garcia JF, Perez-Garcia M. The effects of daily stress and stressful life events on the clinical symptomatology of patients with lupus erythematosus. Psychosom Med. 2004; 66: 788–794. CrossRef
- Hamrick N, Cohen S, Rodriguez MS. Being popular can be healthy or unhealthy: stress, social network diversity, and incidence of upper respiratory infection. Health Psychol. 2002; 21: 294–298. CrossRef
- Folkman S. Personal control and stress and coping processes: A theoretical analysis. J Pers Soc Psychol. 1984; 46: 839–852. CrossRef
- Folkman S, Lazarus RS, Dunkel-Schetter C, De Longis A, Gruen RJ. Dynamics of a stressful encounter: Cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol. 1986; 50: 992–1003. CrossRef
- Maier KJ, Waldstein SR, Synowski SJ. Relation of cognitive appraisal to cardiovascular reactivity, affect, and task engagement. Annals Behav Med. 2003; 26: 32–41. CrossRef
- Bontkes HJ, de Gruijl TD, Walboomers JM, et al. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. J Gen Virol. 1999; 80(Pt 2): 409–417.
- Perceived Stress is Associated with Impaired T-Cell Response to HPV16 in Women with Cervical Dysplasia
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Annals of Behavioral Medicine
Volume 35, Issue 1 , pp 87-96
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Human Papillomavirus
- Cervical Dysplasia
- T-cell Proliferative Response
- Industry Sectors
- Author Affiliations
- 1. Division of Population Science, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, PA, 19012, USA
- 2. Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY, USA
- 3. Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA, USA
- 4. Gynecologic Oncology Institute, Abington Memorial Hospital, Abington, PA, USA
- 5. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
- 7. Division of Allergy and Immunology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
- 8. Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA